Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M642Revenue $M122Net Margin (%)25.8Altman Z-Score9.4
Enterprise Value $M589EPS $0.3Operating Margin %29.1Piotroski F-Score7
P/E(ttm)23.2Beneish M-Score2.9Pre-tax Margin (%)25.8Higher ROA y-yY
Price/Book6.210-y EBITDA Growth Rate %--Quick Ratio3.3Cash flow > EarningsN
Price/Sales4.95-y EBITDA Growth Rate %--Current Ratio3.8Lower Leverage y-yY
Price/Free Cash Flow26.8y-y EBITDA Growth Rate %--ROA % (ttm)30.5Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)61.7Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M47.8ROIC % (ttm)207Gross Margin Increase y-yY

Gurus Latest Trades with SUPN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SUPNGeorge Soros 2015-03-31 Buy 0.01%$8.18 - $12.09
($9.45)
$ 13.4442%New holding107,308
SUPNJoel Greenblatt 2015-03-31 Buy $8.18 - $12.09
($9.45)
$ 13.4442%New holding41,686
SUPNRobert Bruce 2014-12-31 Add0.68%$7.49 - $9.49
($8.4)
$ 13.4460%Add 73.65%694,581
SUPNRobert Bruce 2014-09-30 Add0.73%$7.99 - $11.13
($8.98)
$ 13.4450%Add 300.00%400,000
SUPNRobert Bruce 2014-06-30 Buy 0.25%$7.32 - $10.85
($8.88)
$ 13.4451%New holding100,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SUPN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


SUPN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Bryan Jones W.VP of Business Development 2015-03-30Sell6,712$12.0211.81view
Bryan Jones W.VP of Business Development 2015-03-24Sell1,900$1212view
Bhatt Padmanabh P.Sr. VP of IP; CSO 2013-08-19Sell2,285$8.2163.7view
BIGHAM MICHAELDirector 2013-03-22Buy35,000$5.41148.43view
SIEBERT JOHN MDirector 2013-03-21Buy3,000$5.5144.36view
Khattar Jack A.President, CEO 2013-03-15Buy10,000$6.15118.54view
PATRICK GREGORY SVP, CFO 2013-03-14Buy5,000$6.9593.38view
ORBIMED ADVISORS LLC10% Owner 2013-02-13Sell302,183$7.5578.01view
ORBIMED ADVISORS LLC10% Owner 2012-12-18Sell297,815$6.9294.22view
SIEBERT JOHN MDirector 2012-12-04Buy7,000$8.1465.11view

Press Releases about SUPN :

    Quarterly/Annual Reports about SUPN:

    News about SUPN:

    Articles On GuruFocus.com
    Robert Bruce new Buys Feb 16 2015 
    Third Quarter Was Robert Bruce's Busiest in 2014 Nov 21 2014 
    Supernus Pharmaceuticals Reports Insider Buys Mar 26 2013 

    More From Other Websites
    SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security... May 21 2015
    Supernus to Present at June Jefferies Healthcare Conference May 19 2015
    Supernus to Present at June Jefferies Healthcare Conference May 19 2015
    SUPERNUS PHARMACEUTICALS INC Financials May 15 2015
    SUPERNUS PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report May 06 2015
    Supernus Pharmaceuticals Inc Earnings Call scheduled for 9:00 am ET today May 06 2015
    Supernus Announces First Quarter 2015 Financial Results May 05 2015
    Supernus posts 1Q profit May 05 2015
    Supernus posts 1Q profit May 05 2015
    SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... May 05 2015
    Supernus Announces First Quarter 2015 Financial Results May 05 2015
    Q1 2015 Supernus Pharmaceuticals Inc Earnings Release - After Market Close May 05 2015
    Supernus Pharmaceuticals (SUPN) is Overbought: Is A Drop Coming? - Tale of the Tape Apr 27 2015
    SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Apr 22 2015
    Supernus to Host First Quarter 2015 Earnings Conference Call Apr 21 2015
    Supernus to Host First Quarter 2015 Earnings Conference Call Apr 21 2015
    SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Apr 07 2015
    Supernus Announces Issuance of Sixth U.S. Patent Protecting Trokendi XR(R) Apr 02 2015
    Supernus Announces Issuance of Sixth U.S. Patent Protecting Trokendi XR(R) Apr 02 2015
    Supernus Pharmaceuticals (SUPN) in Focus: Stock Up 5.5% - Tale of the Tape Apr 02 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK